Fulcrum Therapeutics (FULC) Cash & Equivalents (2018 - 2026)
Fulcrum Therapeutics (FULC) recorded Cash & Equivalents of $48.47 million in Q2 2026, up 13.8% from $42.59 million a year earlier but down 3.6% from the prior quarter.
Powered by 
Analysis
Fulcrum Therapeutics (FULC) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Fulcrum Therapeutics reported Cash & Equivalents of $197.53 million, up 239.3% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 28.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $58.21 million in FY2024 (+127.7%), $25.56 million in FY2023 (-27.2%), $35.1 million in FY2022 (-0.9%) and $35.41 million in FY2021 (-37.9%).
- Quarterly Cash & Equivalents has ranged from $25.56 million in Q4 2023 to $197.53 million in Q4 2025 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 57.6% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 239.3% in Q4 2025, against a decline of 66.9% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $50.26 million (Q1 2026), $197.53 million (Q4 2025) and $47.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Fulcrum Therapeutics | 280.73 Mn | 280.73 Mn | - | 48.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.47 Mn |
| Mar 31, 2026 | 50.26 Mn |
| Dec 31, 2025 | 197.53 Mn |
| Sep 30, 2025 | 47.08 Mn |
| Jun 30, 2025 | 42.59 Mn |
| Mar 31, 2025 | 42.18 Mn |
| Dec 31, 2024 | 58.21 Mn |
| Sep 30, 2024 | 72.63 Mn |
| Jun 30, 2024 | 86.70 Mn |
| Mar 31, 2024 | 39.95 Mn |
| Dec 31, 2023 | 25.56 Mn |
| Sep 30, 2023 | 30.08 Mn |
| Jun 30, 2023 | 33.97 Mn |
| Mar 31, 2023 | 34.73 Mn |
| Dec 31, 2022 | 35.10 Mn |
| Sep 30, 2022 | 90.94 Mn |
| Jun 30, 2022 | 40.15 Mn |
| Mar 31, 2022 | 33.31 Mn |
| Dec 31, 2021 | 35.41 Mn |
| Sep 30, 2021 | 65.47 Mn |
API Access
Fulcrum Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FULC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "FULC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=FULC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();